FDA Grants Orphan Drug Designation to Ymmunobio’s CEACAM Antibody for the Treatment of Liver CancerFeb 28
Jan 31Drug Discovery & DevelopmentYmmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
Jan 13Fierce Biotech: Appointment of Michel JanicotMichel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Jun 14, 2022BioPharma DiveYmmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Apr 11, 2022PharmTechYmmunobio AG Signs Patent Purchase Agreement with LeukoGmbH https://www.pharmtech.com/view/ymmunobio-ag-signs-patent-purchase-agreement-w...
